Ratings by Craig-Hallum (Matt G. Hewitt)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2025 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2024 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Champions Oncology | CSBR | Upgrade | Buy (Hold) |
4.07 (5.87) |
44.23% | Details | |
| 3/13/2024 | Champions Oncology | CSBR | Downgrade | Hold (Buy) |
5.67 (5.87) |
3.53% | Details | |
| 12/13/2023 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2023 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details |
